Cargando…

Uveal melanoma-associated cancers revisited

BACKGROUND: Uveal melanoma (UM) is the most common primary ocular malignancy of adults. A small group of patients was found to express familial predisposition. Moreover, it may be preceded or followed by other malignancies elsewhere in the body. We aim to compare the incidence of UM and other associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Alfaar, Ahmad Samir, Saad, Anas, Elzouki, Shiema, Abdel-Rahman, Mohamed H, Strauss, Olaf, Rehak, Matus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705551/
https://www.ncbi.nlm.nih.gov/pubmed/33257317
http://dx.doi.org/10.1136/esmoopen-2020-000990
_version_ 1783616973281689600
author Alfaar, Ahmad Samir
Saad, Anas
Elzouki, Shiema
Abdel-Rahman, Mohamed H
Strauss, Olaf
Rehak, Matus
author_facet Alfaar, Ahmad Samir
Saad, Anas
Elzouki, Shiema
Abdel-Rahman, Mohamed H
Strauss, Olaf
Rehak, Matus
author_sort Alfaar, Ahmad Samir
collection PubMed
description BACKGROUND: Uveal melanoma (UM) is the most common primary ocular malignancy of adults. A small group of patients was found to express familial predisposition. Moreover, it may be preceded or followed by other malignancies elsewhere in the body. We aim to compare the incidence of UM and other associated cancers and study the factors that may influence each condition. PATIENTS AND METHODS: We have collected the data from the Surveillance, Epidemiology and End Results database of nine US cancer registries for UM patients between 1973 and 2015. We calculated the standardised incidence ratios for single primary UM, first primary and second primary UM, and compared the groups for multiple factors. RESULTS: A total of 4946 patients were included in the study; 3863 with single primary UM, 646 developed a second primary malignancy following UM, and 437 patients developed second primary UM following a previous primary malignancy. The risk of developing UM increased after leukaemia, melanoma of the skin and prostate. On the other side, the risk of developing melanoma of the skin, thyroid, renal and other eye and orbit malignancies has increased significantly after initial UM. This risk was more evident in the age group between 50 and 70 years old. Cancer-specific survival was significantly higher in UM associated with other malignancies group compared with single primary UM. CONCLUSION: Our study showed a different behaviour of the UM when associated with other tumours that exceed the known spectrum of hereditary UM. Further studies are required to dissect the genetic background of this behaviour.
format Online
Article
Text
id pubmed-7705551
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-77055512020-12-09 Uveal melanoma-associated cancers revisited Alfaar, Ahmad Samir Saad, Anas Elzouki, Shiema Abdel-Rahman, Mohamed H Strauss, Olaf Rehak, Matus ESMO Open Original Research BACKGROUND: Uveal melanoma (UM) is the most common primary ocular malignancy of adults. A small group of patients was found to express familial predisposition. Moreover, it may be preceded or followed by other malignancies elsewhere in the body. We aim to compare the incidence of UM and other associated cancers and study the factors that may influence each condition. PATIENTS AND METHODS: We have collected the data from the Surveillance, Epidemiology and End Results database of nine US cancer registries for UM patients between 1973 and 2015. We calculated the standardised incidence ratios for single primary UM, first primary and second primary UM, and compared the groups for multiple factors. RESULTS: A total of 4946 patients were included in the study; 3863 with single primary UM, 646 developed a second primary malignancy following UM, and 437 patients developed second primary UM following a previous primary malignancy. The risk of developing UM increased after leukaemia, melanoma of the skin and prostate. On the other side, the risk of developing melanoma of the skin, thyroid, renal and other eye and orbit malignancies has increased significantly after initial UM. This risk was more evident in the age group between 50 and 70 years old. Cancer-specific survival was significantly higher in UM associated with other malignancies group compared with single primary UM. CONCLUSION: Our study showed a different behaviour of the UM when associated with other tumours that exceed the known spectrum of hereditary UM. Further studies are required to dissect the genetic background of this behaviour. BMJ Publishing Group 2020-11-30 /pmc/articles/PMC7705551/ /pubmed/33257317 http://dx.doi.org/10.1136/esmoopen-2020-000990 Text en © Author (s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, any changes made are indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Original Research
Alfaar, Ahmad Samir
Saad, Anas
Elzouki, Shiema
Abdel-Rahman, Mohamed H
Strauss, Olaf
Rehak, Matus
Uveal melanoma-associated cancers revisited
title Uveal melanoma-associated cancers revisited
title_full Uveal melanoma-associated cancers revisited
title_fullStr Uveal melanoma-associated cancers revisited
title_full_unstemmed Uveal melanoma-associated cancers revisited
title_short Uveal melanoma-associated cancers revisited
title_sort uveal melanoma-associated cancers revisited
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705551/
https://www.ncbi.nlm.nih.gov/pubmed/33257317
http://dx.doi.org/10.1136/esmoopen-2020-000990
work_keys_str_mv AT alfaarahmadsamir uvealmelanomaassociatedcancersrevisited
AT saadanas uvealmelanomaassociatedcancersrevisited
AT elzoukishiema uvealmelanomaassociatedcancersrevisited
AT abdelrahmanmohamedh uvealmelanomaassociatedcancersrevisited
AT straussolaf uvealmelanomaassociatedcancersrevisited
AT rehakmatus uvealmelanomaassociatedcancersrevisited